U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Sarcomatoid mesothelioma

MedGen UID:
137774
•Concept ID:
C0334513
•
Neoplastic Process
Synonyms: Fibrous mesothelioma; Fibrous mesothelioma, malignant; malignant fibrous mesothelioma; malignant fibrous mesothelioma (morphologic abnormality); Sarcomatoid Mesothelioma; sarcomatoid mesothelioma; sarcomatoid mesothelioma (morphologic abnormality); Spindled mesothelioma; spindled mesothelioma
SNOMED CT: Sarcomatoid mesothelioma (399477001); Spindled mesothelioma (399477001); Fibrous mesothelioma, malignant (54443001); Fibrous mesothelioma (54443001)
 
Monarch Initiative: MONDO:0006407

Definition

A malignant neoplasm arising from mesothelial cells. It is characterized by the presence of spindle cells. Anaplastic morphologic features and multinucleated malignant cells may also be seen. [from NCI]

Professional guidelines

PubMed

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.
Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson AG, Roggli V, Travis WD, Wick M; International Mesothelioma Interest Group
Arch Pathol Lab Med 2013 May;137(5):647-67. Epub 2012 Aug 28 doi: 10.5858/arpa.2012-0214-OA. PMID: 22929121
Pathohistological diagnosis and differential diagnosis.
Tischoff I, Neid M, Neumann V, Tannapfel A
Recent Results Cancer Res 2011;189:57-78. doi: 10.1007/978-3-642-10862-4_5. PMID: 21479896
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.
Husain AN, Colby TV, Ordóñez NG, Krausz T, Borczuk A, Cagle PT, Chirieac LR, Churg A, Galateau-Salle F, Gibbs AR, Gown AM, Hammar SP, Litzky LA, Roggli VL, Travis WD, Wick MR
Arch Pathol Lab Med 2009 Aug;133(8):1317-31. doi: 10.5858/133.8.1317. PMID: 19653732

Recent clinical studies

Etiology

Asbestos-induced mesothelial injury and carcinogenesis: Involvement of iron and reactive oxygen species.
Okazaki Y
Pathol Int 2022 Feb;72(2):83-95. Epub 2021 Dec 29 doi: 10.1111/pin.13196. PMID: 34965001
Spindle cell tumors of the pleura and the peritoneum: pathologic diagnosis and updates.
Boyraz B, Hung YP
APMIS 2022 Mar;130(3):140-154. Epub 2022 Jan 11 doi: 10.1111/apm.13203. PMID: 34942046
Pathohistological diagnosis and differential diagnosis.
Tischoff I, Neid M, Neumann V, Tannapfel A
Recent Results Cancer Res 2011;189:57-78. doi: 10.1007/978-3-642-10862-4_5. PMID: 21479896
Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry.
Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A, Inai K
Pathol Int 2008 Feb;58(2):75-83. doi: 10.1111/j.1440-1827.2007.02193.x. PMID: 18199156
Biomarkers for mesothelioma.
Scherpereel A, Lee YC
Curr Opin Pulm Med 2007 Jul;13(4):339-443. doi: 10.1097/MCP.0b013e32812144bb. PMID: 17534183

Diagnosis

Sarcoma of the Lung and Mediastinum.
Yoshida KI, Yoshida A
Surg Pathol Clin 2024 Jun;17(2):243-255. Epub 2023 Dec 15 doi: 10.1016/j.path.2023.11.008. PMID: 38692808
Sarcomatoid Mesothelioma: A Clinicopathological and Immunohistochemical Study of 64 Cases.
Oramas DM, Zaleski M, Moran CA
Int J Surg Pathol 2021 Dec;29(8):820-825. Epub 2021 May 3 doi: 10.1177/10668969211014256. PMID: 33939493
Revisiting localized malignant mesothelioma.
Mann S, Khawar S, Moran C, Kalhor N
Ann Diagn Pathol 2019 Apr;39:74-77. Epub 2019 Feb 19 doi: 10.1016/j.anndiagpath.2019.02.014. PMID: 30798074
Pathohistological diagnosis and differential diagnosis.
Tischoff I, Neid M, Neumann V, Tannapfel A
Recent Results Cancer Res 2011;189:57-78. doi: 10.1007/978-3-642-10862-4_5. PMID: 21479896
Biomarkers for mesothelioma.
Scherpereel A, Lee YC
Curr Opin Pulm Med 2007 Jul;13(4):339-443. doi: 10.1097/MCP.0b013e32812144bb. PMID: 17534183

Therapy

Tumor suppressor effect of an antibody on xenotransplanted sarcomatoid mesothelioma cells.
Hasegawa M, Hanamatsu Y, Saigo C, Kito Y, Takeuchi T
Thorac Cancer 2022 Sep;13(18):2566-2573. Epub 2022 Aug 2 doi: 10.1111/1759-7714.14591. PMID: 35916358Free PMC Article
Asbestos-induced mesothelial injury and carcinogenesis: Involvement of iron and reactive oxygen species.
Okazaki Y
Pathol Int 2022 Feb;72(2):83-95. Epub 2021 Dec 29 doi: 10.1111/pin.13196. PMID: 34965001
Revisiting localized malignant mesothelioma.
Mann S, Khawar S, Moran C, Kalhor N
Ann Diagn Pathol 2019 Apr;39:74-77. Epub 2019 Feb 19 doi: 10.1016/j.anndiagpath.2019.02.014. PMID: 30798074
Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials.
Mansfield AS, Symanowski JT, Peikert T
Lung Cancer 2014 Nov;86(2):133-6. Epub 2014 Sep 1 doi: 10.1016/j.lungcan.2014.08.017. PMID: 25217189Free PMC Article
Tumors of serosal tissue origin.
Bolen JW
Clin Lab Med 1987 Mar;7(1):31-50. PMID: 3549129

Prognosis

Spindle cell tumors of the pleura and the peritoneum: pathologic diagnosis and updates.
Boyraz B, Hung YP
APMIS 2022 Mar;130(3):140-154. Epub 2022 Jan 11 doi: 10.1111/apm.13203. PMID: 34942046
Revisiting localized malignant mesothelioma.
Mann S, Khawar S, Moran C, Kalhor N
Ann Diagn Pathol 2019 Apr;39:74-77. Epub 2019 Feb 19 doi: 10.1016/j.anndiagpath.2019.02.014. PMID: 30798074
The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification.
Galateau-Salle F, Churg A, Roggli V, Travis WD; World Health Organization Committee for Tumors of the Pleura
J Thorac Oncol 2016 Feb;11(2):142-54. doi: 10.1016/j.jtho.2015.11.005. PMID: 26811225
Pathohistological diagnosis and differential diagnosis.
Tischoff I, Neid M, Neumann V, Tannapfel A
Recent Results Cancer Res 2011;189:57-78. doi: 10.1007/978-3-642-10862-4_5. PMID: 21479896
Biomarkers for mesothelioma.
Scherpereel A, Lee YC
Curr Opin Pulm Med 2007 Jul;13(4):339-443. doi: 10.1097/MCP.0b013e32812144bb. PMID: 17534183

Clinical prediction guides

Loss of Methylthioadenosine Phosphorylase by Immunohistochemistry Is Common in Pulmonary Sarcomatoid Carcinoma and Sarcomatoid Mesothelioma.
Terra S, Roden AC, Yi ES, Aubry MC, Boland JM
Am J Clin Pathol 2022 Jan 6;157(1):33-39. doi: 10.1093/ajcp/aqab091. PMID: 34463336
The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
Marchevsky AM, LeStang N, Hiroshima K, Pelosi G, Attanoos R, Churg A, Chirieac L, Dacic S, Husain A, Khoor A, Klebe S, Lantuejoul S, Roggli V, Vignaud JM, Weynard B, Sauter J, Henderson D, Nabeshima K, Galateau-Salle F
Hum Pathol 2017 Sep;67:160-168. Epub 2017 Aug 4 doi: 10.1016/j.humpath.2017.07.015. PMID: 28782639
The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification.
Galateau-Salle F, Churg A, Roggli V, Travis WD; World Health Organization Committee for Tumors of the Pleura
J Thorac Oncol 2016 Feb;11(2):142-54. doi: 10.1016/j.jtho.2015.11.005. PMID: 26811225
Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases.
Klebe S, Brownlee NA, Mahar A, Burchette JL, Sporn TA, Vollmer RT, Roggli VL
Mod Pathol 2010 Mar;23(3):470-9. Epub 2010 Jan 15 doi: 10.1038/modpathol.2009.180. PMID: 20081811
Biomarkers for mesothelioma.
Scherpereel A, Lee YC
Curr Opin Pulm Med 2007 Jul;13(4):339-443. doi: 10.1097/MCP.0b013e32812144bb. PMID: 17534183

Recent systematic reviews

Diagnostic performance of immunohistochemistry markers for malignant pleural mesothelioma diagnosis and subtypes. A systematic review and meta-analysis.
Parra-Medina R, Castañeda-González JP, Chaves-Cabezas V, Alzate JP, Chaves JJ
Pathol Res Pract 2024 May;257:155276. Epub 2024 Mar 30 doi: 10.1016/j.prp.2024.155276. PMID: 38603842
The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
Marchevsky AM, LeStang N, Hiroshima K, Pelosi G, Attanoos R, Churg A, Chirieac L, Dacic S, Husain A, Khoor A, Klebe S, Lantuejoul S, Roggli V, Vignaud JM, Weynard B, Sauter J, Henderson D, Nabeshima K, Galateau-Salle F
Hum Pathol 2017 Sep;67:160-168. Epub 2017 Aug 4 doi: 10.1016/j.humpath.2017.07.015. PMID: 28782639
Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials.
Mansfield AS, Symanowski JT, Peikert T
Lung Cancer 2014 Nov;86(2):133-6. Epub 2014 Sep 1 doi: 10.1016/j.lungcan.2014.08.017. PMID: 25217189Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...